A Rockville-based biotech company at the forefront of the malaria vaccine effort will benefit from a $29 million grant from the Bill and Melinda Gates Foundation.
The PATH Malaria Vaccine Initiative will channel most of the Gates grant to Sanaria Inc., which has spent $14 million developing a viable malaria vaccine.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.